However, this study did not perform in vitro hepatocyte experiments or gene knockout/overexpression in the livers of animal models to further verify the role of the PI3K/Akt and MAPK pathways in ART improvement in T2DM. The gene discussed is AKT1; the disease is type 2 diabetes mellitus.